Vialwirebiotech, curated
July 21, 2026, 6:30 PM
July 7, 2026
- 2:02 PM · Pharmaceutical Executive2:02 PM<![CDATA[Catalent Announces Expanded Partnership with Nanoscope Therapeutics]]> — Pharmaceutical Executive
- 12:17 PM · BioPharma Dive12:17 PMOberland pours up to $400M into MeiraGTx eye gene therapies — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMOpus aligns with FDA on rare eye disease gene therapy trial — BioWorld
- 12:00 PM · BioWorld12:00 PMWuxi Apptec seeks immediate relief from US listing — BioWorld
- 12:00 PM · BioWorld12:00 PMEG427 raises $37.7M series C for HSV gene therapy — BioWorld
- 12:00 PM · BioWorld12:00 PM340B reforms coming to the congressional table — BioWorld
- 12:00 PM · BioWorld12:00 PMNeuracle eyes Shanghai IPO as global BCI funding surges — BioWorld
- 12:00 PM · BioWorld12:00 PMYes we Can-Fite PDAC; phase IIa results add momentum — BioWorld
- 12:00 PM · BioWorld12:00 PMWith tardy Tvardi phase I win, skin in STAT3 game plus GI — BioWorld
- 12:00 PM · BioWorld12:00 PMEndocrinology becomes Vertex’s fifth pillar with $10B Crinetics buy — BioWorld
- 12:00 PM · BioWorld12:00 PMVera’s Trutakna wins FDA nod as first dual inhibitor for IgAN — BioWorld
- 12:00 PM · BioWorld12:00 PMBellaseno speeds breast scaffold trial as J&J deal clears path to market — BioWorld
- 11:59 AM · BioPharma Dive11:59 AMKailera says obesity pill succeeds in late-stage trial in China — BioPharma Dive
- 11:02 AM · TechCrunch11:02 AMChemistry Ventures is raising $500M for its second fund — TechCrunch
- 10:31 AM · Pharmaceutical Technology10:31 AMMerck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline — Pharmaceutical Technology
- 9:51 AM · SCMP — Tech9:51 AMHong Kong IVF clinic ordered to suspend most services after embryo specimen errors — SCMP — Tech
- 9:00 AM · BioWorld9:00 AMMira reports results on optimized oral formulation of SKNY-1 — BioWorld
- 9:00 AM · BioWorld9:00 AMAstrazeneca returns to tap China’s CSPC in $1.7B discovery deal — BioWorld
- 8:00 AM · Drug Discovery World8:00 AMFDA expands use of Casgevy to children as young as two — Drug Discovery World
- 8:00 AM · BioWorld8:00 AMHK biotech listings gain traction in Q2 with trio of June IPOs — BioWorld
- 6:00 AM · Drug Discovery World6:00 AMBioptimus partners with French cancer research organisation — Drug Discovery World
- 5:00 AM · Drug Discovery World5:00 AMBioCryst winds down internal discovery programmes — Drug Discovery World
- 4:54 AM · Pharmaceutical Technology4:54 AMEC approves AbbVie’s Tepkinly combination for follicular lymphoma — Pharmaceutical Technology
July 6, 2026
- 10:45 AM · BioPharma Dive10:45 AMGene editing developer Scribe plots an IPO — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMAscletis submits INDs for ASC-36 and ASC-36_35 for obesity — BioWorld
- 6:05 AM · Pharmaceutical Technology6:05 AMRoche pens $490m Astex breast cancer license deal — Pharmaceutical Technology
- 4:56 AM · Pharmaceutical Technology4:56 AMBesins Healthcare boosts drug delivery portfolio with UniD deal — Pharmaceutical Technology
- 4:02 AM · FT — Pharmaceuticals4:02 AMNovartis to buy UK biotech in $1.5bn deal — FT — Pharmaceuticals
- 2:58 AM · Bloomberg — Technology2:58 AMNovartis to Buy Cancer-Drug Firm Myricx for Up to $1.5 Billion — Bloomberg — Technology